Douglas Evan Godshall, President & CEO at Shockwave Medical, Inc. (SWAV), sold 10,000 shares at $200.05 ($2.0M) on 2024-01-05, disclosed to the SEC on 2024-01-08.
Scheduled sale ($2.0M) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| SWAV | SELL | 2023-12-18 | $1.7M | — | Filing → |
| SWAV | SELL | 2023-11-17 | $1.2M | — | Filing → |
| SWAV | SELL | 2023-10-17 | $2.8M | — | Filing → |